GLP‑1 Receptor Agonist Use Across Preconception, Pregnancy, and the Postpartum P
GLP-1 RA use in pregnancy remains controversial due to limited human data. This review synthesizes available evidence on risks and benefits across reproductive stages.
Medical Cannabis Evidence-Based Care: Endocannabinoid System Clinical Research and Cannabinoid Dosing in Family Medicine
Clinical Takeaway Prenatal alcohol exposure frequently occurs alongside use of other substances including cannabis, tobacco, and opioids, meaning clinical screening must address polysubstance use rather than alcohol alone. Identifying co-occurring…
Associations of Prenatal Cannabis Exposure and Neonatal Brain Development in the HBCD Cohort.
A major cohort study demonstrates that prenatal cannabis exposure brain development effects are detectable through neuroimaging in newborns. This research provides objective evidence supporting current recommendations to avoid cannabis during pregnancy…
Perceived Safety of Cannabis Use During Pregnancy and Changes in Perception over Time (2017-2021): A National Survey of US Adults.
CED Clinical Relevance #56Monitored Relevance Early-stage or contextual signal requiring further evidence before action. 🔬 Evidence Watch | CED Clinic PregnancySafetyPublic HealthPatient EducationSurvey…
Cannabis in Pregnancy: 5 Crucial Insights
Cannabis in Pregnancy: 5 Crucial Insights Essential Science and Real-World Guidance for Expectant Mothers In today’s fast-paced world—where stress, politics, and the endless digital hustle often leave us questioning every decision—the issue of…